OSBPL2 and colorectal carcinoma: Briefly, this study illustrates that OSBPL2 defect collaborates with ECM Collagen I to promote colorectal tumor growth and metastasis through two independent pathways and provides the basis for appropriate therapy using ERK and PARP1 inhibitors to treat OSBPL2Low CRC.